Evidence map›Paper›PMID 26348349›Full record

ArticlePloS one2015

Benzoic Acid-Inducible Gene Expression in Mycobacteria.

Marte S Dragset, Amy K Barczak, Nisha Kannan, Mali Mærk, Trude H Flo, Svein Valla, Eric J Rubin, Magnus Steigedal

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Marte S DragsetDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America; Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Biotechnology, Norwegian University of Science and Technology, Trondheim, Norway.
Amy K BarczakMassachusetts General Hospital, Department of Medicine, Boston, Massachusetts, United States of America.
Nisha KannanCentre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Mali MærkCentre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Trude H FloCentre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Svein VallaDepartment of Biotechnology, Norwegian University of Science and Technology, Trondheim, Norway.
Eric J RubinDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America.
Magnus SteigedalDepartment of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, Massachusetts, United States of America; Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Central Norway Regional Health Authority, Stjørdal, Norway.
Norwegian University of Science and Technology · NOCentral Norway Regional Health Authority · NOHarvard University · USMassachusetts General Hospital · US

Funding

INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
NIAID NIH HHS T32 AI007061
6 · The paper itself

Abstract

Conditional expression is a powerful tool to investigate the role of bacterial genes. Here, we adapt the Pseudomonas putida-derived positively regulated XylS/Pm expression system to control inducible gene expression in Mycobacterium smegmatis and Mycobacterium tuberculosis, the causative agent of human tuberculosis. By making simple changes to a Gram-negative broad-host-range XylS/Pm-regulated gene expression vector, we prove that it is possible to adapt this well-studied expression system to non-Gram-negative species. With the benzoic acid-derived inducer m-toluate, we achieve a robust, time- and dose-dependent reversible induction of Pm-mediated expression in mycobacteria, with low background expression levels. XylS/Pm is thus an important addition to existing mycobacterial expression tools, especially when low basal expression is of particular importance.

Indexed as

Bacterial ProteinsBenzoic AcidGene Expression Regulation, BacterialGenetic VectorsHumansMycobacterium smegmatisMycobacterium tuberculosisPromoter Regions, GeneticPseudomonas putidaTrans-ActivatorsTuberculosisBacterial ProteinsBenzoic AcidTrans-ActivatorsXylS protein, Pseudomonas putida

Identifiers

PMID26348349
PMCPMC4562662
OpenAlexW2108677109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.